Results

Total Results: 601 records

Showing results for "cardiac".
Users also searched for: ekg

261. Making Healthcare Safer IV_Rapid Response: Reducing Adverse Drug Events Related to Anticoagulant Use in Adults (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mhs-IV-high-risk-drugs-rapid-response.pdf
     January 01, 2024 - app-based clinical decision support for atrial fibrillation management.20,23-25 Remote monitoring of cardiac … or software) for anticoagulation monitoring Moderate CCT = controlled clinical trial; CRT-D = cardiac … resynchronization therapy defibrillator; ICD = implantable cardiac defibrillator; PM = pacemaker; PSP … 0.80) AF = atrial fibrillation; CCT = controlled clinical trial; CI = confidence interval; CRT-D = cardiac … resynchronization therapy defibrillator; HR = hazard ratio; ICD = implantable cardiac defibrillator

262. Automated-Entry Patient Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/health-data-mapping/protocol
     March 01, 2021 - conditions: obesity, diabetes prevention, hypertension, sleep apnea, coronary artery disease, heart failure, cardiac … thrombos*:ti OR calcif*:ti)) 21 Heart Failure 'heart failure'/exp OR (((heart OR cardio* OR cardiac

263. Vitamin D and Calcium: A Systematic Review of Health Outcomes | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/vitamin-d-calcium/research-protocol
     December 01, 2019 - studies: Placebo, nonfortified/supplemented food Outcomes CVD clinical outcomes Cardiac … These comprise the following clinical and related intermediary outcomes: CVD clinical outcomes (cardiac

264. Antipsychotics for the Prevention and Treatment of Delirium: A Systematic Review | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/antipsychotics/research-protocol
     January 01, 2019 - use Hospice enrollment Adverse effects of intervention(s) Sedation Weight gain Changes in appetite Cardiac … facility; sitter use; hospice enrollment) Adverse effects (sedation; weight gain; changes in appetite; cardiac

265. Antipsychotics for the Prevention and Treatment of Delirium: A Systematic Review (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/delirium-research-protocol.pdf
     June 01, 2018 - enrollment o Adverse effects of intervention(s)  Sedation  Weight gain  Changes in appetite  Cardiac … sitter use; hospice enrollment) o Adverse effects (sedation; weight gain; changes in appetite; cardiac

266. Antipsychotics-Children Research-Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/antipsychotics-children_research-protocol.pdf
     June 04, 2010 - ketoacidosis • Neuroleptic malignant syndrome • Seizures • Tardive dyskinesia • Cardiomyopathies • Cardiac … diabetic ketoacidosis, neuroleptic malignant syndrome, seizures, tardive dyskinesia, cardiomyopathies and cardiac … agranulocytosis 2. seizures 3. myocarditis 4. cardiovascular and respiratory effects, (respiratory and/or cardiac

267. Diagnostic Errors in the Emergency Department: A Systematic Review | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/diagnostic-errors-emergency/research
     February 01, 2023 - intracranial hemorrhage, (10) arterial thromboembolism, (11) spinal and intracranial abscess, (12) cardiac

268. Local Therapies for the Treatment of Stage I Non-Small Cell Lung Cancer and Endobronchial Obstruction Due to Advanced Lung Tumors | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/lung-cancer-nonsurgical-therapies/research-protocol
     December 01, 2019 - patients with stage-I NSCLC are deemed medically inoperable, primarily because of pre-existing diminished cardiac … not surgical candidates because of the presence of contraindications to major surgery, for example, cardiac … surgical candidates because of the documented presence of contraindications to major surgery, for example, cardiac

269. Cer-250-Cannabis-Table-E5-2022-Update 0 (xls file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-table-e5-2022-update_0.xlsx
     January 01, 2022 - treatment related adverse event: 21.1% (71/337) vs. 35.0% (118/337), RR 0.60 (95% CI 0.47 to 0.77) Cardiac

270. Effectiveness of Isosorbide Dinitrate and Hydralazine in Racial/Ethnic Subgroups With Heart Failure | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/congestive-heart-failure-medicines/research
     January 01, 2020 - Trandolapril Cardiac Evaluation (TRACE) Study Group [see comments]. … Widowed 12% 12 COMORBIDITY (Quan 13 modification of Elixhauser 30 ) Cardiac

271. Comparative Effectiveness and Safety of Analgesics for Osteoarthritis – An Update to the 2006 Report | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/osteoarthritis-pain/research-protocol
     December 01, 2019 - Less is known about COX-3, which is found in the cerebral cortex and cardiac tissue and appears to be … limitation of observational studies of NSAIDs was that none simultaneously assessed the risk for serious cardiac

272. Microsoft Word - Comp Eff 10.doc (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-2007_research-2007-1.pdf
     January 01, 2007 - The renin system is an important mediator of blood volume, arterial pressure, and cardiac and vascular … hormone, leading to fluid retention; stimulates thirst; promotes adrenergic function; and increases cardiac … hormone, leading to fluid retention; stimulates thirst; promotes adrenergic function; and increases cardiac … Comparative effects of chronic ACE inhibition and AT1 receptor blocked losartan on cardiac hypertrophy … term effects of losartan and enalapril, alone or with a diuretic, on ambulatory blood pressure and cardiac

273. Vitamin-D-Calcium-Protocol-130611 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/vitamin-d-calcium_research-protocol.pdf
     September 13, 2013 - studies:  Placebo, nonfortified/supplemented food • Outcomes o CVD clinical outcomes  Cardiac … These comprise the following clinical and related intermediary outcomes: • CVD clinical outcomes (cardiac

274. Modeling to evaluate benefits and harms of new diagnostic tests compared to established diagnostic tests – uses and limitations (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/benefits-harms-modeling_research.pdf
     November 19, 2009 - analyses contrasted 17 technologies (tests) and 4 combinations thereof for the diagnosis of acute cardiac … Evaluation of technologies for identifying acute cardiac ischemia in emergency departments.

275. Comparative Effectiveness of First and Second Generation Antipsychotics in the Adult Population | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/antipsychotics-adults/research-protocol
     December 01, 2019 - diabetic ketoacidosis, neuroleptic malignant syndrome, seizures, tardive dyskinesia, cardiomyopathies and cardiac … diabetic ketoacidosis, neuroleptic malignant syndrome, seizures, tardive dyskinesia, cardiomyopathies and cardiac … 2. seizures 3. myocarditis 4. cardiovascular and respiratory effects, (respiratory and/or cardiac

276. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - Adverse events associated with azithromycin included hearing loss and cardiac arrhythmias and concerns … dissuade a physician from prescribing it for prophylaxis in COPD patients include hearing loss and cardiac … These caveats—risks of hearing loss, cardiac arrhythmias, and antibiotic resistance—are factors that

277. Layout 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_executive.pdf
     January 01, 2006 - Less is known about COX-3, which is found in the cerebral cortex and cardiac tissue and appears to be … found rofecoxib associated with increased risks of arrhythmia (primarily ventricular fibrillation, cardiac … arrest, or sudden cardiac death) and renal dysfunction (peripheral edema, hypertension, or renal dysfunction

278. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_disposition-comments.pdf
     October 01, 2010 - Journal of Interventional Cardiac Electrophysiology. 2006;15:145-155. … inclusion: The bulk of the evidence demonstrating the effectiveness of RFA for AF, and its effects on cardiac … However it should be noted that the patient populations included in these studies referenced for cardiac … drug therapy including cardiovascular death, occurrence of disabling stroke, serious bleeding and cardiac

279. Management of Infantile Hemangioma (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_clinician.pdf
     June 01, 2016 - were found to be risk factors for PHACE syndrome (posterior fossa malformations, arterial anomalies, cardiac

280. Disposition of Comments for CER 168 Infantile Hemangioma (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_disposition-comments.pdf
     January 15, 2016 - TEP reviewer #5 Introduction 2/20-24- Propranolol was already available as a cardiac drug before 2014 … several small reported series' of infants with symptomatic hepatic hemangiomas, often with associated cardiac … propranolol with beneficial effects (via improvement noted on imaging, and decreased reliance of their cardiac